Clinical Trials Logo
  1. Home
  2. Vulvar Diseases
  3. NCT05890092
  4. Details
NCT05890092 Clinical Trial

Vulvar Disease in Nigeria Observational Study

Vulvar Diseases Clinical Trial

— VdiN  

Official title:
Vulvar Disease in Nigeria - Registry ( Observationsl Study)

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05890092
Other study ID # KDRS-NGR001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 3, 2023
Est. completion date November 30, 2026

Study information
Verified date May 2023
Source KDRS ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Recruitment information / eligibility
Status Recruiting
Enrollment 1000
Est. completion date November 30, 2026
Est. primary completion date May 2, 2026
Accepts healthy volunteers
Gender Female
Age group 10 Years to 90 Years
Eligibility Inclusion Criteria: - biological females - afab Exclusion Criteria: - none-afab

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Observation
Observing for disease prevalence - actual and self-reported

Locations
Country Name City State
United Kingdom Kdrs London

Sponsors (1)
Lead Sponsor Collaborator
KDRS ltd

Country where clinical trial is conducted

United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of Vulvar disease Awareness of Vulvar disease (descriptor) 1-12 months
See also
  Status Clinical Trial Phase
Completed NCT05478746 - Effects of Flourish HEC on Localized Provoked Vulvodynia N/A
Not yet recruiting NCT06070454 - Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions N/A
Completed NCT00004316 - Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Phase 1/Phase 2
Recruiting NCT05592626 - A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT02858310 - E7 TCR T Cells for Human Papillomavirus-Associated Cancers Phase 1/Phase 2
Terminated NCT03444727 - Treatment Prior to Injection and Biopsy of the Vulva N/A
Recruiting NCT06075264 - Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) Phase 2
Completed NCT00496184 - Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis Phase 3
Recruiting NCT00119886 - Botox on Vulvar Vestibulitis Phase 4
Active, not recruiting NCT03792516 - Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) Phase 1